ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Pulmonology
Nomogram to predict severe Mycoplasma pneumoniae pneumonia in children
Provisionally accepted
- 1Xuzhou Children's Hospital, Xuzhou, China
- 2The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background Mycoplasma pneumoniae pneumonia (MPP) is a prevalent community-acquired pneumonia in children, and severe MPP (SMPP) poses a prominent threat to pediatric health with rapid progression, high complication rates, and increased clinical management burden. Clinically, the capacity to identify children at high risk of SMPP remains inadequate. The aim of this study was to develop and validate a nomogram for predicting SMPP in children with MPP. Methods A total of 475 children with MPP admitted to Xuzhou Children's Hospital from Jan. 2023 to Dec. 2024 were enrolled, meeting specific inclusion/exclusion criteria. They were categorized into severe MPP (SMPP, n=151) and non-SMPP (n=324) groups, then randomly split into training (n=332) and validation (n=143) cohorts at a 7:3 ratio. Demographic, clinical, laboratory data and derived inflammatory indicators were collected. LASSO and multivariate logistic regression were used to construct a nomogram, with ROC, calibration curves and DCA for evaluation. The study was ethically approved. Results Using LASSO and multivariate logistic regression analyses, fever duration (OR=1.271, P<0.0001), red blood cell count (OR=0.300, P=0.0069) and albumin (OR=0.795, P=0.0002) were identified as independent predictors. The nomogram showed good discrimination (training cohort AUC=0.8574, 95%CI:0.8162-0.8986; validation cohort AUC=0.8147, 95%CI:0.7435-0.8859). The Hosmer-Lemeshow test yielded P=0.551 in the training set and P=0.553 in the validation set, and calibration curves in both cohorts confirmed excellent model fit, while DCA verified substantial clinical utility, supporting the nomogram's clinical value in pediatric SMPP prediction Conclusion We developed and validated a practical, user-friendly nomogram for predicting SMPP in children with MPP, which could facilitate early identification and risk stratification of SMPP.
Keywords: Mycoplasma pneumoniae pneumonia, nomogram, Prediction model, Risk factors, Severe Mycoplasma pneumoniae pneumonia
Received: 29 Oct 2025; Accepted: 30 Jan 2026.
Copyright: © 2026 Zhang, Min, Gong and Gao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Liang Gong
Keyu Gao
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.